The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.15 (0.10%)
Spread: 4.50 (3.093%)
Open: 147.60
High: 147.75
Low: 147.60
Prev. Close: 147.60
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

2 May 2019 16:45

RNS Number : 9464X
Santander UK Plc
02 May 2019
 

Companies Act 2006

 

Resolutions of

SANTANDER UK PLC

 (the "Company")

 

 

At the ANNUAL GENERAL MEETING OF THE COMPANY, duly convened and held at 10:00 a.m. on 2 May 2019 at 2 Triton Square, Regent's Place, London, NW1 3AN, the following resolutions were duly passed.

 

Resolutions 7 to 11 were passed as Special Resolutions:

 

Special Resolutions

 

7. THAT the Company be authorised, without conditions, to buy back its own 8⅝% preference shares. The following terms apply:

 

(a) The Company may buy back up to 125,000,000 8⅝% preference shares;

 

(b) The lowest price which the Company can pay for 8⅝% preference shares is 75% of the average of the market values of the preference shares for five business days before the purchase is made; and

 

(c) The highest price (not including expenses) which the Company can pay for each 8⅝% preference share is 125% of the average of the market values of the preference shares for five business days before the purchase is made.

 

This authority shall begin on the date of the passing of this resolution and end on the conclusion of the next Annual General Meeting of the Company. The Company may agree, before this authorisation ends, to buy back its own 8⅝% preference shares even though the purchase may be completed after this authorisation ends.

 

8. THAT the Company be authorised, without conditions, to buy back its own 10⅜% preference shares. The following terms apply:

 

(a) The Company may buy up to 200,000,000 10⅜% preference shares;

 

(b) The lowest price which the Company can pay for 10⅜% preference shares is 75% of the average of the market values of the preference shares for five business days before the purchase is made; and

 

(c) The highest price (not including expenses) which the Company can pay for each 10⅜% preference share is 125% of the average of the market values of the preference shares for five business days before the purchase is made.

 

This authority shall begin on the date of the passing of this resolution and end on the conclusion of the next Annual General Meeting of the Company. The Company may agree, before this authorisation ends, to buy back its own 10⅜% preference shares even though the purchase may be completed after this authorisation ends.

 

9. THAT the Company be authorised, without conditions, to buy back its own Series A Fixed/Floating Rate Non-Cumulative Callable Preference Shares. The following terms apply:

 

(a) The Company may buy up to 13,780 Series A Fixed/Floating Rate Non-Cumulative Callable Preference Shares;

 

(b) The lowest price which the Company can pay for Series A Fixed/Floating Rate Non-Cumulative Callable Preference Shares is 75% of the average of the market values of the preference shares for five business days before the purchase is made; and

 

(c) The highest price (not including expenses) which the Company can pay for each Series A Fixed/Floating Rate Non-Cumulative Callable Preference Shares is 125% of the average of the market values of the preference shares for five business days before the purchase is made.

 

This authority shall begin on the date of the passing of this resolution and end on the conclusion of the next Annual General Meeting of the Company. The Company may agree, before this authorisation ends, to buy back its own Series A Fixed/Floating Rate Non-Cumulative Callable Preference Shares even though the purchase may be completed after this authorisation ends.

 

10. THAT the Articles of Association be amended so that the text of sub-article 13.2 is deleted and the following text is inserted in its place:

 

"Subject to article 13.3, the quorum for directors' meetings may be fixed from time to time by a decision of the directors, but (subject to article 13.3) it must never be less than two, and unless otherwise fixed it is two, of which at least one is an Independent Non-Executive Director."

 

11. THAT the Articles of Association of the Company be amended by inserting a new Article 27 as follows:

 

"RETIREMENT OF DIRECTORS BY ROTATION

 

At each annual general meeting of the Company every Director shall retire from office. A retiring Director may offer himself or herself for re-appointment by the members and a Director that is so re-appointed will be treated as continuing in office without a break."

The existing Articles of Association shall be renumbered accordingly.

 

 

 

 

 

 

 

 

__________________

Certified as a true copy

Gavin White

Company Secretary

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEASSAELDNEFF
Date   Source Headline
17th Aug 20181:17 pmRNSForm 8.3 - Shire plc
17th Aug 20181:16 pmRNSForm 8.3 - Shire plc
17th Aug 20181:15 pmRNSForm 8.3 - Shire plc
14th Aug 20181:47 pmRNSPublication of Final Terms
10th Aug 20185:28 pmRNSPublication of Suppl.Prospcts
10th Aug 20187:15 amRNSHalf-year Report
10th Aug 20187:15 amRNSHalf-year Report
25th Jul 20182:24 pmRNSPublication of Suppl.Prospcts
25th Jul 20182:16 pmRNSPublication of Suppl.Prospcts
25th Jul 20187:15 amRNSQuarterly Management Statement - 30 June 2018
9th Jul 20184:24 pmRNSArticle 8
9th Jul 201812:02 pmRNSNotice of Delisting
25th Jun 201812:31 pmRNSPublication of Suppl.Prospcts
25th Jun 201812:26 pmRNSPublication of Suppl.Prospcts
13th Jun 201810:47 amRNSApproval of Ring-Fencing Transfer Scheme
31st May 201810:53 amRNSDirectorate Change
14th May 20182:24 pmRNSArticle 8
14th May 201811:29 amRNSNotice of Delisting - Series 1125
8th May 20184:21 pmRNSPublication of Final Terms
8th May 20183:26 pmRNSPublication of Final Terms
4th May 201812:41 pmRNSPublication of Final Terms
27th Apr 20184:47 pmRNSStatement re Change of Paying & Transfer Agent
27th Apr 201811:46 amRNSNotice Change of Agent
24th Apr 20186:15 pmRNSPublication of a Prospectus
24th Apr 20182:36 pmRNSPublication of Suppl.Prospcts
24th Apr 20187:15 amRNS1st Quarter Results
13th Apr 20182:16 pmRNSPublication of Final Terms
11th Apr 20184:49 pmRNSOffer period extension Series 1125-1126
29th Mar 201811:29 amRNSArticle 8
28th Mar 20185:11 pmRNSPublication of Final Terms
26th Mar 20184:27 pmRNSArticle 8
19th Mar 20182:29 pmRNSDelisting notice - Series 1121 - XS1710683985
19th Mar 201811:52 amRNSArticle 8
12th Mar 201810:40 amRNSCall notice XS0907246812. Series 790
9th Mar 20183:46 pmRNSPublication of Final Terms
2nd Mar 20184:31 pmRNSPre-Stab: Santander, GBP 50m Tap, due 27/02/2020
2nd Mar 20184:14 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:10 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:02 pmRNSPublication of Final Terms
2nd Mar 20183:58 pmRNSPublication of Final Terms
28th Feb 201812:45 pmRNSAnnual Financial Report
28th Feb 201812:40 pmRNSAnnual Financial Report
26th Feb 20185:20 pmRNSPublication of Final Terms
23rd Feb 20182:47 pmRNSArticle 8
22nd Feb 20185:34 pmRNSPre-Stab Notice - SANUK, GBP 250m, due 27/02/2020
12th Feb 201810:58 amRNSNotice of Early Redemption
7th Feb 20185:43 pmRNSPublication of Suppl.Prospcts
7th Feb 20185:39 pmRNSPublication of Suppl.Prospcts
6th Feb 201811:41 amRNSUpdate on Ring-fencing & Part VII Transfer Scheme
31st Jan 20187:15 amRNSQ4 17 - Quarterly Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.